Mayne Pharma Group Ltd (MYX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.086x

Based on the latest financial reports, Mayne Pharma Group Ltd (MYX) has a cash flow conversion efficiency ratio of 0.086x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$31.98 Million ≈ $22.63 Million USD) by net assets (AU$370.28 Million ≈ $262.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MYX defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Mayne Pharma Group Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Mayne Pharma Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mayne Pharma Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mayne Pharma Group Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
EcoSynthetix Inc TO:ECO	0.014x
São Carlos Empreendimentos e Participações S.A SA:SCAR3	-0.037x
Vytrus Biotech S.A. MC:VYT	0.022x
Nynomic AG F:M7U	-0.045x
Genovis AB (publ.) ST:GENO	0.059x
ANDHRA PAPER LIMITED NSE:ANDHRAPAP	0.033x
Purple Capital Ltd JSE:PPE	0.014x
GrafTech International Ltd NYSE:EAF	0.080x

Annual Cash Flow Conversion Efficiency for Mayne Pharma Group Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Mayne Pharma Group Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see MYX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$370.28 Million ≈ $262.00 Million	AU$17.47 Million ≈ $12.36 Million	0.047x	+240.05%
2024-06-30	AU$454.19 Million ≈ $321.37 Million	AU$-15.30 Million ≈ $-10.83 Million	-0.034x	+49.97%
2023-06-30	AU$634.36 Million ≈ $448.85 Million	AU$-42.71 Million ≈ $-30.22 Million	-0.067x	-420.56%
2022-06-30	AU$557.12 Million ≈ $394.20 Million	AU$-7.21 Million ≈ $-5.10 Million	-0.013x	-121.12%
2021-06-30	AU$771.58 Million ≈ $545.94 Million	AU$47.26 Million ≈ $33.44 Million	0.061x	-36.02%
2020-06-30	AU$1.04 Billion ≈ $737.50 Million	AU$99.78 Million ≈ $70.60 Million	0.096x	-8.94%
2019-06-30	AU$1.01 Billion ≈ $717.52 Million	AU$106.61 Million ≈ $75.43 Million	0.105x	+6.87%
2018-06-30	AU$1.24 Billion ≈ $873.95 Million	AU$121.50 Million ≈ $85.97 Million	0.098x	+947.27%
2017-06-30	AU$1.31 Billion ≈ $928.62 Million	AU$-15.24 Million ≈ $-10.78 Million	-0.012x	-108.16%
2016-06-30	AU$376.22 Million ≈ $266.20 Million	AU$53.50 Million ≈ $37.86 Million	0.142x	+104.38%
2015-06-30	AU$322.20 Million ≈ $227.98 Million	AU$22.42 Million ≈ $15.86 Million	0.070x	-57.60%
2014-06-30	AU$159.27 Million ≈ $112.70 Million	AU$26.14 Million ≈ $18.49 Million	0.164x	+189.81%
2013-06-30	AU$120.89 Million ≈ $85.54 Million	AU$6.84 Million ≈ $4.84 Million	0.057x	-87.06%
2012-06-30	AU$30.60 Million ≈ $21.65 Million	AU$13.39 Million ≈ $9.47 Million	0.437x	+158.83%
2011-06-30	AU$24.17 Million ≈ $17.10 Million	AU$4.09 Million ≈ $2.89 Million	0.169x	-57.89%
2010-06-30	AU$25.55 Million ≈ $18.08 Million	AU$10.26 Million ≈ $7.26 Million	0.401x	+186.15%
2009-06-30	AU$7.70 Million ≈ $5.45 Million	AU$-3.59 Million ≈ $-2.54 Million	-0.466x	-76.14%
2008-06-30	AU$11.44 Million ≈ $8.09 Million	AU$-3.03 Million ≈ $-2.14 Million	-0.265x	-209.97%
2007-06-30	AU$14.51 Million ≈ $10.27 Million	AU$-1.24 Million ≈ $-876.47K	-0.085x	--

About Mayne Pharma Group Ltd

AU:MYX Australia Medical Distribution

Market Cap

$135.09 Million

AU$190.93 Million AUD

Market Cap Rank

#18130 Global

#556 in Australia

Share Price

AU$2.35

Change (1 day)

+0.00%

52-Week Range

AU$2.13 - AU$6.30

All Time High

AU$41.75